132 related articles for article (PubMed ID: 28031922)
1. Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein.
Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
Future Sci OA; 2015 Nov; 1(4):FSO71. PubMed ID: 28031922
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force.
Thomsen LB; Linemann T; Birkelund S; Tarp GA; Moos T
Materials (Basel); 2019 Oct; 12(21):. PubMed ID: 31683542
[TBL] [Abstract][Full Text] [Related]
3. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
Kang YS; Jung HJ; Oh JS; Song DY
CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
[TBL] [Abstract][Full Text] [Related]
4. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
5. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
[TBL] [Abstract][Full Text] [Related]
6. Dual ligand immunoliposomes for drug delivery to the brain.
Loureiro JA; Gomes B; Fricker G; Cardoso I; Ribeiro CA; Gaiteiro C; Coelho MA; Pereira Mdo C; Rocha S
Colloids Surf B Biointerfaces; 2015 Oct; 134():213-9. PubMed ID: 26204501
[TBL] [Abstract][Full Text] [Related]
7. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
[TBL] [Abstract][Full Text] [Related]
8. Brain drug delivery of small molecules using immunoliposomes.
Huwyler J; Wu D; Pardridge WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14164-9. PubMed ID: 8943078
[TBL] [Abstract][Full Text] [Related]
9. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
[TBL] [Abstract][Full Text] [Related]
10. Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma.
Johnsen KB; Burkhart A; Melander F; Kempen PJ; Vejlebo JB; Siupka P; Nielsen MS; Andresen TL; Moos T
Sci Rep; 2017 Sep; 7(1):10396. PubMed ID: 28871203
[TBL] [Abstract][Full Text] [Related]
11. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
Huwyler J; Yang J; Pardridge WM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
[TBL] [Abstract][Full Text] [Related]
12. By-passing of P-glycoprotein using immunoliposomes.
Huwyler J; Cerletti A; Fricker G; Eberle AN; Drewe J
J Drug Target; 2002 Feb; 10(1):73-9. PubMed ID: 11996089
[TBL] [Abstract][Full Text] [Related]
13. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
Johnsen KB; Moos T
J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
[TBL] [Abstract][Full Text] [Related]
14. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
Schnyder A; Krähenbühl S; Drewe J; Huwyler J
J Drug Target; 2005 Jun; 13(5):325-35. PubMed ID: 16199376
[TBL] [Abstract][Full Text] [Related]
15. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes.
Zhao H; Li GL; Wang RZ; Li SF; Wei JJ; Feng M; Zhao YJ; Ma WB; Yang Y; Li YN; Kong YG
J Int Med Res; 2010; 38(3):957-66. PubMed ID: 20819432
[TBL] [Abstract][Full Text] [Related]
17. Brain-Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha-Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease.
Sela M; Poley M; Mora-Raimundo P; Kagan S; Avital A; Kaduri M; Chen G; Adir O; Rozencweig A; Weiss Y; Sade O; Leichtmann-Bardoogo Y; Simchi L; Aga-Mizrachi S; Bell B; Yeretz-Peretz Y; Or AZ; Choudhary A; Rosh I; Cordeiro D; Cohen-Adiv S; Berdichevsky Y; Odeh A; Shklover J; Shainsky-Roitman J; Schroeder JE; Hershkovitz D; Hasson P; Ashkenazi A; Stern S; Laviv T; Ben-Zvi A; Avital A; Ashery U; Maoz BM; Schroeder A
Adv Mater; 2023 Dec; 35(51):e2304654. PubMed ID: 37753928
[TBL] [Abstract][Full Text] [Related]
18. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
19. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
[TBL] [Abstract][Full Text] [Related]
20. Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes.
Gregori M; Orlando A; Re F; Sesana S; Nardo L; Salerno D; Mantegazza F; Salvati E; Zito A; Malavasi F; Masserini M; Cazzaniga E
J Pharm Sci; 2016 Jan; 105(1):276-83. PubMed ID: 26852859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
